DUBLIN–(BUSINESS WIRE)–The “Opioids Market by Product and Application: Global Opportunity Analysis and Industry Forecast, 2019-2026” report has been added to ResearchAndMarkets.com’s offering.
The global opioids market was valued at $18,532.8 million in 2018, and is expected to reach $22,387.2 million by 2026, registering a CAGR of 3.2% from 2019 to 2026.
The growth of the global opioids market is driven by alarming an increase in incidence of orthopedic diseases & chronic pain. Furthermore, rise in disposable income and a surge in global geriatric population are expected to propel the growth of the global opioids market.
However, emergence and legalization of cannabis as an alternative to opioids impede the growth of the market. On the contrary, an increase in consumption of opioid analgesic for pain management in developing countries is anticipated to create lucrative opportunities for market expansion in the near future.
The global opioid market is segmented into product, application, and region. Depending on product, the market is categorized into codeine, fentanyl, methadone, oxycodone, morphine, and hydrocodone. The applications covered in the market include pain management, cough treatment, and diarrhea treatment.
The pain management segment is further classified into neuropathic pain, migraine, back pain, osteoarthritis pain, cancer pain, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Benefits of the Report
- The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
- It offers a quantitative analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
- Comprehensive analysis of all geographical regions is provided to determine the prevailing opportunities.
- Key players are profiled, and their strategies are analyzed thoroughly to understand the competitive outlook of the global market.
Key Topics Covered:
Chapter 1: Introduction
Chapter 2: Executive Summary
2.1. Cxo Perspective
Chapter 3: Market Overview
3.1. Market Definition And Scope
3.2. Porter’S Five Forces Analysis
3.3. Top Player Positioning
3.4. Market Dynamics
184.108.40.206. Increase Use of Opioids In Pain Management
220.127.116.11. Upsurge In Consumption of Opioids In Developing Economies
18.104.22.168. Implementation of Stringent Government Regulation Toward Vigorous Prescription
22.214.171.124. Opioid Crisis Across The Globe
3.4.3. Impacting Factors
Chapter 4: Opioids Market, By Product
4.1.1. Market Size And Forecast, By Product Type
4.2.1. Key Market Trends
4.2.2. Market Size And Forecast, By Region
4.2.3. Market Analysis, By Country
4.3.1. Key Market Trends
4.3.2. Market Size And Forecast, By Region
4.3.3. Market Analysis, By Country
4.4.1. Key Market Trends
4.4.2. Market Size And Forecast, By Region
4.4.3. Market Analysis, By Country
4.5.1. Key Market Trends
4.5.2. Market Size And Forecast
4.5.3. Market Analysis, By Country
4.6.1. Key Market Trends
4.6.2. Market Size And Forecast
4.6.3. Market Analysis, By Country
4.7.1. Key Market Trends
4.7.2. Market Size And Forecast
4.7.3. Market Analysis, By Country
4.8.1. Key Market Trends
4.8.2. Market Size And Forecast
4.8.3. Market Analysis, By Country
Chapter 5: Opioids Market, By Application
5.1.1. Market Size And Forecast, By Application
5.2. Pain Management
5.2.1. Market Size And Forecast, By Region
5.2.2. Market Analysis, By Country
126.96.36.199. Neuropathic Pain
188.8.131.52.1. Market Size And Forecast
184.108.40.206.1. Market Size And Forecast
220.127.116.11. Back Pain
18.104.22.168.1. Market Size And Forecast
22.214.171.124. Osteoarthritis Pain
126.96.36.199.1. Market Size And Forecast
188.8.131.52. Cancer Pain
184.108.40.206.1. Market Size And Forecast
220.127.116.11.1. Market Size And Forecast
5.3. Cough Treatment
5.3.1. Market Size And Forecast, By Region
5.3.2. Market Analysis, By Country
5.4. Diarrhea Treatment
5.4.1. Market Size And Forecast, By Region
5.4.2. Market Analysis, By Country
Chapter 6: Opioids Market, By Region
6.2. North America
Chapter 7: Compony Profiles
7.1. Allergan Plc.
7.2. Boehringer Ingelheim Group
7.3. Endo Pharmaceuticals Inc. (Par Pharmaceutical)
7.4. Johnson & Johnson (Janssen Global Services, Llc)
7.5. Mallinckrodt Plc (Specgx Llc)
7.6. Pfizer Inc.
7.7. Purdue Pharma L.P.
7.8. Sanofi S.A.
7.9. Sun Pharmaceutical Industries Ltd.
7.10. Teva Pharmaceutical Industries Limited
For more information about this report visit https://www.researchandmarkets.com/r/wg59lz